Measuring biological age using omics data
J Rutledge, H Oh, T Wyss-Coray - Nature Reviews Genetics, 2022 - nature.com
Age is the key risk factor for diseases and disabilities of the elderly. Efforts to tackle age-
related diseases and increase healthspan have suggested targeting the ageing process …
related diseases and increase healthspan have suggested targeting the ageing process …
Immortal time bias in pharmacoepidemiology
S Suissa - American journal of epidemiology, 2008 - academic.oup.com
Immortal time is a span of cohort follow-up during which, because of exposure definition, the
outcome under study could not occur. Bias from immortal time was first identified in the …
outcome under study could not occur. Bias from immortal time was first identified in the …
Postdiagnosis smoking cessation and reduced risk for lung cancer progression and mortality: a prospective cohort study
M Sheikh, A Mukeriya, O Shangina… - Annals of internal …, 2021 - acpjournals.org
Background: Lung cancer is the leading cause of cancer death worldwide, and about one
half of patients with lung cancer are active smokers at diagnosis. Objective: To determine …
half of patients with lung cancer are active smokers at diagnosis. Objective: To determine …
Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study
R Ramos, M Comas-Cufí, R Martí-Lluch, E Balló… - bmj, 2018 - bmj.com
Objective To assess whether statin treatment is associated with a reduction in
atherosclerotic cardiovascular disease (CVD) and mortality in old and very old adults with …
atherosclerotic cardiovascular disease (CVD) and mortality in old and very old adults with …
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
Problem of immortal time bias in cohort studies: example using statins for preventing
progression of diabetes | The BMJ Skip to main content Intended for healthcare …
progression of diabetes | The BMJ Skip to main content Intended for healthcare …
Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis
M Shah, M Avgil Tsadok, CA Jackevicius, V Essebag… - Circulation, 2014 - Am Heart Assoc
Background—Current observational studies on warfarin use and the risk for stroke and
bleeding in patients with atrial fibrillation (AF) undergoing dialysis found conflicting results …
bleeding in patients with atrial fibrillation (AF) undergoing dialysis found conflicting results …
Oral contraceptives, hormone replacement therapy, and stroke risk
T Johansson, P Fowler, WE Ek, A Skalkidou… - Stroke, 2022 - Am Heart Assoc
Background: Millions of women worldwide use exogenous hormones as oral contraceptives
or hormone replacement therapy. Still, time-dependent and long-term consequences of …
or hormone replacement therapy. Still, time-dependent and long-term consequences of …
Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome
Context Prior mechanistic studies reported that omeprazole decreases the platelet inhibitory
effects of clopidogrel, yet the clinical significance of these findings is not clear. Objective To …
effects of clopidogrel, yet the clinical significance of these findings is not clear. Objective To …
[PDF][PDF] Vitamin E improves transplant‐free survival and hepatic decompensation among patients with nonalcoholic steatohepatitis and advanced fibrosis
Vitamin E improves liver histology in adults with nonalcoholic steatohepatitis (NASH) but not
diabetes, but its impact on long‐term patient outcomes is unknown. We evaluated whether …
diabetes, but its impact on long‐term patient outcomes is unknown. We evaluated whether …
Increased mortality after prosthetic joint infection in primary THA
PH Gundtoft, AB Pedersen, C Varnum… - … and Related Research®, 2017 - Springer
Background Revision for prosthetic joint infection (PJI) has a major effect on patients' health
but it remains unclear if early PJI after primary THA is associated with a high mortality …
but it remains unclear if early PJI after primary THA is associated with a high mortality …